| Cimetidine inhibits epidermal growth factor-induced cell signaling. | |
| | |
MedLine Citation:
|
PMID: 17295779 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Cimetidine, a histamine-2 (H2) receptor antagonist, has been demonstrated to have anticancer effects on colorectal cancer, melanoma and renal cell carcinoma. In the current study, we clarified that cimetidine inhibits both epidermal growth factor (EGF)-induced cell proliferation and migration in hepatocellular carcinoma (HCC) cell lines. METHOD: HCC cell lines (Hep3B, HLF, SK-Hep-1, JHH-2, PLC/PRF/5 and HLE) were used and cell proliferation was assessed by [3H]-thymidine incorporation assay. Cell migration was measured by in vitro cell migration assay. Biological effects of cimetidine were assessed with human EGF receptor (EGFR)-expressing mouse fibroblast cells (NR6-WT). The autophosphorylation of EGFR and the activation of other downstream effectors were analyzed by immunoprecipitation and immunoblotting. The concentration of intracellular cyclic AMP (cAMP) was measured by competitive enzyme immunoassay. RESULTS: Cimetidine inhibited both EGF-induced cell proliferation and migration in Hep3B, HLF, SK-Hep-1 and JHH-2, while cimetidine did not affect EGF-induced cell proliferation and migration in PLC/PRF/5 and HLE. Cimetidine was revealed to disrupt the EGF-induced autophosphorylation of EGFR and its downstream effectors, mitogen activated protein kinases and phospholipase C-gamma. To define the molecular basis of this negative regulation, we identified that cimetidine significantly decreased intracellular cAMP levels and that decrement of cAMP inhibited autophosphorylation of EGFR. The cell permeable cAMP analog, CPT-cAMPS reversed the cimetidine-induced inhibition of EGF-induced cell proliferation and cell migration by restoring autophosphorylation of EGFR. CONCLUSION: Cimetidine inhibited EGF-induced cell proliferation and migration in HCC cell lines by decreasing the concentration of intracellular cAMP levels. Cimetidine may be a candidate chemopreventive agent for HCC. |
| | |
Authors:
|
Tatsuya Fujikawa; Hidenori Shiraha; Yutaka Nakanishi; Nobuyuki Takaoka; Naoki Ueda; Mayumi Suzuki; Yasushi Shiratori |
Related Documents
:
|
15756029 - Farnesyltransferase inhibitors and human malignant pleural mesothelioma: a first-step c... 6582309 - Modulation by retinoic acid of cellular, surface-exposed, and secreted glycoconjugates ... 10470859 - Mannose 6-phosphate/insulin-like growth factor ii receptor mediates the growth-inhibito... 2684689 - Ras protein expression is developmentally regulated in embryonic chicken brain. 7585519 - The h-ras oncogene interferes with retinoic acid signaling and metabolism in nih3t3 cells. 8125159 - Contrasting morphological changes in pc12 flat cells expressing two different forms of ... 20654499 - Effects of pentachlorophenol and hydroxylated polychlorinated biphenyls on thyroid horm... 3485589 - Reduced repair of potentially lethal radiation damage in glutathione synthetase-deficie... 16138329 - Spatially controlled co-culture of neurons and glial cells. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of gastroenterology and hepatology Volume: 22 ISSN: 0815-9319 ISO Abbreviation: J. Gastroenterol. Hepatol. Publication Date: 2007 Mar |
Date Detail:
|
Created Date: 2007-02-13 Completed Date: 2007-07-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8607909 Medline TA: J Gastroenterol Hepatol Country: Australia |
Other Details:
|
Languages: eng Pagination: 436-43 Citation Subset: IM |
Affiliation:
|
Department of Medicine and Medical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan. tfmty@yahoo.co.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Carcinoma, Hepatocellular
/
drug therapy,
pathology* Cell Movement / drug effects*, physiology* Cell Proliferation / drug effects* Cimetidine / pharmacology*, therapeutic use Epidermal Growth Factor / antagonists & inhibitors*, physiology* Histamine H2 Antagonists / pharmacology*, therapeutic use Humans Liver Neoplasms / drug therapy, pathology* Tumor Cells, Cultured |
| Chemical | |
Reg. No./Substance:
|
0/Histamine H2 Antagonists; 51481-61-9/Cimetidine; 62229-50-9/Epidermal Growth Factor |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Free oxygen radicals reduce bile flow in rats via an intracellular cyclic AMP-dependent mechanism.
Next Document: Colo-colic intussusception associated with Henoch-Schönlein purpura in adults.